AIM
CLB icon

Aigen Investment Management’s Core Laboratories CLB Stock Holding History

Aigen Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,297
Closed -$239K – 643
2025
Q3 		$239K Sell
19,297
-11,194
-37% -$131K 0.04% 610
2025
Q2 		$351K Buy
+30,491
New +$362K 0.05% 484
2024
Q2 		– Sell
-12,320
Closed -$210K – 807
2024
Q1 		$210K Sell
12,320
-2,955
-19% -$46.5K 0.05% 531
2023
Q4 		$270K Buy
+15,275
New +$308K 0.05% 530
2020
Q4 		– Sell
-2,341
Closed -$36K – 809
2020
Q3 		$36K Buy
+2,341
New +$49.1K ﹤0.01% 774
2020
Q2 		– Sell
-61,099
Closed -$632K – 887
2020
Q1 		$632K Buy
61,099
+30,382
+99% +$850K 0.08% 354
2019
Q4 		$1.16M Buy
+30,717
New +$1.38M 0.19% 146

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aigen Investment Management's CLB Position: Q4 2025 in Review

Aigen Investment Management sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 19,297 shares — an estimated $239K sold.

Aigen Investment Management first reported a position in CLB in Q4 2019 and held it in 7 quarters. The position peaked at $1.16M in Q4 2019. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

  • Aigen Investment Management reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
  • Aigen Investment Management sold 19,297 Core Laboratories shares in Q4 2025, an estimated $239K.
  • Aigen Investment Management first reported a position in Core Laboratories in Q4 2019 and held it in 7 quarters.
  • Aigen Investment Management's Core Laboratories position peaked at $1.16M in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Aigen Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.